Intervention to Reduce Serious Mental Illness & Suicide Stigma Among

Status Recruiting

Clinical Trial Summary

The team aims to develop and test the efficacy of a serious mental illness (SMI) and suicide ideation and attempt (SIA) stigma reduction intervention for medical students. The team expects that after intervention exposure, relative to control group, participants in the experimental condition will manifest more favorable change in knowledge, attitudes, and behaviors.

Clinical Trial Description

People with serious mental illness (PSMI; i.e. Schizophrenia and bipolar disorder) die, on average, 25 years earlier than the general population. Suicide is a key factor for this disparity as it is the leading cause of unnatural deaths among this population. Research identifies Latinos as a particularly vulnerable group, accounting for one of the highest rates (over 30%) of serious mental illness (SMI) among ethnic minorities in the United States (US). Latinos also hold one of the highest prevalence of suicide ideation and attempts (SIA) with rates of 10.1% and 4.4% respectively. This scenario worsens for one Latino subgroup, Puerto Ricans, who have the highest prevalence of SMI (36%) and SIA among Latinos in the US (7.9% and 3.5% respectively). Taken together, these facts present a concerning scenario for Latinos, especially Puerto Ricans with SMI/SIA. Health professionals play a key role in identifying SMI/SIA among patients; unfortunately, SMI/SIA stigma hinders this process. The proposed study aims to: 1) develop the content of an intervention to reduce SMI/SIA stigma among medical students, 2) determine the acceptability and feasibility of implementing the intervention among medical students by examining recruitment/screening procedures, participation/refusal/retention rates, and participant satisfaction, and; 3) pilot test the preliminary efficacy of the intervention in reducing SMI/SIA stigma among medical students by increasing knowledge of SMI and SIA, reducing negative attitudes towards SMI/SIA and increasing behavioral skills for providing healthcare to PSMI. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05325320
Study type	Interventional
Source	Ponce Medical School Foundation, Inc.
Contact	Eliut Rivera-Segarra, Ph.D
Phone	787-840-2575
Email	elrivera@psm.edu
Status	Recruiting
Phase	N/A
Start date	April 6, 2022
Completion date	May 2023

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05755165` - Adolescent Depression: Video Ads on Instagram	N/A
Completed	`NCT03750864` - Innovative Approach to Reduce Lung Cancer Stigma	N/A
Completed	`NCT05124665` - Interrupting HIV and TB Stigma in the Household in Uganda	N/A
Completed	`NCT03695393` - Stigma, Risk Behaviors and Health Care Among HIV-infected Russian People Who Inject Drugs	N/A
Recruiting	`NCT04420442` - Scar Resection and Reconstruction With Integra and Split Skin Grafts in Patients With Non-Suicidal Self-Inflicted Scars	N/A
Completed	`NCT05596305` - Outcomes of Anti Stigma Educational Intervention of Ungraduated Medical Students	N/A
Completed	`NCT04087954` - Evaluation the Impact of Self-Stigma Reduction Program on Psychosocial Outcomes Among People Diagnosed With Schizophrenia	N/A
Recruiting	`NCT02280889` - Quality of Life and Stigmatization in Children With Congenital Melanocytic Nevi Before and After Nevus Excision
Active, not recruiting	`NCT05907174` - Siyakhana Peer: Evaluating a Peer Recovery Coach Model to Reduce Substance Use Stigma in South African HIV Care	N/A
Recruiting	`NCT05785169` - Ending the HIV Epidemic With Equity: an Intervention to Reduce the Impact of Racism and Discrimination	N/A
Recruiting	`NCT06402929` - Honest, Open, Proud - College for Post-Secondary Students With Mental Health Challenges	N/A
Recruiting	`NCT06316804` - Mobile Mental Health Stigma Reduction Intervention Among Black Adults	N/A
Not yet recruiting	`NCT05415891` - The IMPROV Project: Improving Mental Health and Substance Use Treatment Provision (IMPROV) Among People Living With HIV (Human Immunodeficiency Virus) in Atlanta	N/A
Completed	`NCT05980832` - Effect of Peer-Supported Psychosocial Skills Training in Individuals With Chronic Mental Disorder	N/A
Completed	`NCT04644978` - European Study on the Attitude of Psychiatrists Towards Their Patients
Completed	`NCT02101697` - Reducing AIDS Stigma Among Health Professionals in India	N/A
Completed	`NCT05271903` - Simulation Training for Labor and Delivery Providers to Address HIV Stigma During Childbirth in Tanzania	N/A
Completed	`NCT05935345` - Addressing Nonsuicidal Self-injury in Schools	N/A
Completed	`NCT05770804` - Young Women on Sexual and Reproductive Health Knowledge and Stigma Levels	N/A
Completed	`NCT03231761` - Impact of Video Presentations on Medical Students' Attitudes Toward Mental Illness	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Intervention to Reduce Serious Mental Illness and Suicide Stigma Among Medical Students

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms